CPC
HALO icon

Cookson Peirce & Co’s Halozyme HALO Stock Holding History

Cookson Peirce & Co’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-315,378
Closed -$18.1M – 283
2024
Q3 		$18.1M Buy
+315,378
New +$18.1M 0.85% 40
2023
Q1 		– Sell
-46,272
Closed -$2.63M – 233
2022
Q4 		$2.63M Sell
46,272
-4,659
-9% -$239K 0.17% 70
2022
Q3 		$2.01M Buy
50,931
+629
+1% +$27.8K 0.14% 83
2022
Q2 		$2.21M Buy
+50,302
New +$2.18M 0.15% 82

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Cookson Peirce & Co's HALO Position: Q4 2024 in Review

Cookson Peirce & Co sold out of Halozyme (HALO) in Q4 2024, closing a stake of 315,378 shares — an estimated $18.1M sold.

Cookson Peirce & Co first reported a position in HALO in Q2 2022 and held it in 4 quarters. The position peaked at $18.1M in Q3 2024. 508 funds tracked by Wall St. Rank hold HALO as of Q4 2024.

  • Cookson Peirce & Co reported no remaining Halozyme position as of Q4 2024 after selling out during the quarter.
  • Cookson Peirce & Co sold 315,378 Halozyme shares in Q4 2024, an estimated $18.1M.
  • Cookson Peirce & Co first reported a position in Halozyme in Q2 2022 and held it in 4 quarters.
  • Cookson Peirce & Co's Halozyme position peaked at $18.1M in Q3 2024.
  • 508 funds tracked by Wall St. Rank held Halozyme as of Q4 2024.

Based on Cookson Peirce & Co's 13F filing for Q4 2024, filed 6 Feb 2025.